Concepedia

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Jacopo Sabbatinelli, Angelica Giuliani, Giulia Matacchione, Silvia Latini, Noemi Laprovitera, Giovanni Pomponio, Alessia Ferrarini, Marianna Pavani, Marco Moretti, Armando Gabrielli,

Mechanisms of Ageing and Development · 2020 · 115 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 29.1K citations · Full text

, , +12

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Qiurong Ruan, Kun Yang, Wenxia Wang et al. · Intensive Care Medicine · 2020 · 5.2K citations · Full text

, , +10

Effective treatment of severe COVID-19 patients with tocilizumab

Xiaoling Xu, Mingfeng Han, Tiantian Li et al. · Proceedings of the National Academy of Sciences · 2020 · 2.8K citations · Full text

, , +17

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao et al. · Nature Medicine · 2020 · 1.7K citations · Full text

, , +16

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso et al. · The Lancet · 2020 · 1.6K citations · Full text

, , +15